Chromosome 6q deletion correlates with poor prognosis and low relative expression of FOXO3 in chronic lymphocytic leukemia patients

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

JAROŠOVÁ Marie HRUBA M. OLTOVÁ Alexandra PLEVOVÁ Karla KRUZOVA L. KRIEGOVA E. FILLEROVA R. KORIŤÁKOVÁ Eva DOUBEK Michael LYSAK D. PROCHAZKA V. MRÁZ Marek INDRAK K. PAPAJIK T.

Year of publication 2017
Type Article in Periodical
Magazine / Source American Journal of Hematology
MU Faculty or unit

Faculty of Medicine

Citation
Doi http://dx.doi.org/10.1002/ajh.24852
Field Oncology and hematology
Keywords Chromosome 6q
Description Detection of genetic changes has improved the current risk stratification in chronic lymphocytic leukemia (CLL).1,2 Among the known recurrent chromosomal abnormalities,1 6q deletion is less frequent and controversy surrounding its prognostic significance still remains.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.